| abstract |
The present disclosure relates to a bispecific antibody construct comprising a first binding domain that binds to human CD70 on the surface of a target cell and a second binding domain that binds to human CD3 on the surface of a T cell. Furthermore, the disclosure provides a polynucleotide encoding an antibody construct, a vector comprising said polynucleotide, and a host cell transformed or transfected with said polynucleotide or vector. Furthermore, the present disclosure provides methods for producing the antibody constructs of the present disclosure, medical uses of the antibody constructs, and kits comprising the antibody constructs. [Selection] Figure 1 |